{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T17:02:00Z","timestamp":1743008520447,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":14,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071624722"},{"type":"electronic","value":"9781071624739"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-2473-9_2","type":"book-chapter","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T17:03:45Z","timestamp":1657818225000},"page":"15-19","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the Efficacy of Saracatinib-Loaded Nanoparticles in Lymphatic Metastases of HNSCC with the Aid of Bioluminescence Imaging"],"prefix":"10.1007","author":[{"given":"Liwei","family":"Lang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1056\/NEJMra1715715","volume":"382","author":"LQ Chow","year":"2020","unstructured":"Chow LQ (2020) Head and neck cancer. N Engl J Med 382:60\u201372","journal-title":"N Engl J Med"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"x173","DOI":"10.1093\/annonc\/mds299","volume":"23","author":"B Braakhuis","year":"2012","unstructured":"Braakhuis B, Brakenhoff R, Ren\u00e9 Leemans C (2012) Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors. Ann Oncol 23:x173\u2013x177","journal-title":"Ann Oncol"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fcell.2019.00052","volume":"7","author":"M Canning","year":"2019","unstructured":"Canning M, Guo G, Yu M, Myint C, Groves MW, Byrd JK, Cui Y (2019) Heterogeneity of the head and neck squamous cell carcinoma immune landscape and its impact on immunotherapy. Front Cell Dev Biol 7:52","journal-title":"Front Cell Dev Biol"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.1038\/sj.onc.1203912","volume":"19","author":"RB Irby","year":"2000","unstructured":"Irby RB, Yeatman TJ (2000) Role of Src expression and activation in human cancer. Oncogene 19:5636\u20135642","journal-title":"Oncogene"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1023\/A:1023772912750","volume":"22","author":"JM Summy","year":"2003","unstructured":"Summy JM, Gallick GE (2003) Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22:337\u2013358","journal-title":"Cancer Metastasis Rev"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-017-0485-0","volume":"10","author":"Y Teng","year":"2017","unstructured":"Teng Y, Cai Y, Pi W, Gao L, Shay C (2017) Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity. J Hematol Oncol 10:1\u201310","journal-title":"J Hematol Oncol"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1158\/1078-0432.CCR-09-1834","volume":"16","author":"EL Mayer","year":"2010","unstructured":"Mayer EL, Krop IE (2010) Advances in targeting SRC in the treatment of breast cancer and other solid malignancies. Clin Cancer Res 16:3526\u20133532","journal-title":"Clin Cancer Res"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1158\/1078-0432.CCR-07-1902","volume":"13","author":"S Kopetz","year":"2007","unstructured":"Kopetz S, Shah AN, Gallick GE (2007) Src continues aging: current and future clinical directions. Clin Cancer Res 13:7232\u20137236","journal-title":"Clin Cancer Res"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-018-0623-3","volume":"11","author":"L Lang","year":"2018","unstructured":"Lang L, Shay C, Xiong Y, Thakkar P, Chemmalakuzhy R, Wang X, Teng Y (2018) Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib. J Hematol Oncol 11:1\u201313","journal-title":"J Hematol Oncol"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13045-019-0827-1","volume":"12","author":"L Lang","year":"2019","unstructured":"Lang L, Shay C, Zhao X, Xiong Y, Wang X, Teng Y (2019) Simultaneously inactivating Src and AKT by saracatinib\/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma. J Hematol Oncol 12:132","journal-title":"J Hematol Oncol"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1758-3284-1-32","volume":"1","author":"D Sano","year":"2009","unstructured":"Sano D, Myers JN (2009) Xenograft models of head and neck cancers. Head Neck Oncol 1:32","journal-title":"Head Neck Oncol"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00109-018-1670-5","volume":"96","author":"L Gao","year":"2018","unstructured":"Gao L, Zhao X, Lang L, Shay C, Andrew Yeudall W, Teng Y (2018) Autophagy blockade sensitizes human head and neck squamous cell carcinoma towards CYT997 through enhancing excessively high reactive oxygen species-induced apoptosis. J Mol Med (Berl) 96:929\u2013938","journal-title":"J Mol Med (Berl)"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13046-019-1080-8","volume":"38","author":"L He","year":"2019","unstructured":"He L, Gao L, Shay C, Lang L, Lv F, Teng Y (2019) Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis. J Exp Clin Cancer Res 38:84","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Methods in Molecular Biology","Bioluminescence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2473-9_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T17:03:53Z","timestamp":1657818233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2473-9_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071624722","9781071624739"],"references-count":14,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2473-9_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"15 July 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}